Publications by authors named "J Gotovac"

Background & Aims: Esophageal adenocarcinoma (EAC) develops from its precursor Barrett's esophagus through intermediate stages of low- and high-grade dysplasia. However, knowledge of genetic drivers and molecular mechanisms implicated in disease progression is limited. Herein, we investigated the effect of Mothers against decapentaplegic homolog 4 (SMAD4) loss on transforming growth factor β (TGF-β) signaling functionality and in vivo tumorigenicity in high-grade dysplastic Barrett's cells.

View Article and Find Full Text PDF
Article Synopsis
  • There is a critical need for effective treatment options for patients with oesophageal adenocarcinoma (OAC), as existing targeted therapies have limited effectiveness, particularly anti-HER2 therapy.
  • The study explores the role of growth factor receptor bound protein 7 (GRB7) in OAC, finding it highly expressed in some tumors and linked to poorer survival outcomes; GRB7 knockdown led to reduced tumor growth by affecting cancer cell proliferation and survival pathways.
  • The findings suggest that targeting GRB7 could be a promising therapeutic approach, as the existing HER2-based treatments were ineffective in certain OAC cases, even with high HER2 expression.
View Article and Find Full Text PDF

The transforming growth factor β (TGFβ) signaling pathway governs physiological homeostasis in the gastrointestinal system and its deregulation can lead to a diverse range of human pathologies including juvenile polyposis syndrome and tumor initiation, progression, and metastasis. In gastrointestinal malignancies, tumor cells evade the known tumor suppressive effects of TGFβ signaling through frequent inactivation of the pathway. Paradoxically, tumor cells utilize TGFβ-mediated regulation of epithelial-mesenchymal transition and immunomodulation to facilitate the invasive and migratory phenotype of gastrointestinal cancers and avoid immunosurveillance.

View Article and Find Full Text PDF

Background: The efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in the prevention of local recurrence and disease progression in patients with superficial bladder cancer is very well documented. This study reports the effect of BCG on disease-specific and overall survival.

Patients And Methods: In this retrospective trial, we have analyzed 170 patients with stage Ta and T1 superficial bladder cancer.

View Article and Find Full Text PDF

The article is a discussion of three cases of lipomatosis in the pelvis and of the surgical treatment undertaken in each case. In the first two cases, fatty tissue compressed the lower uriunary tract, and in the third, the rectosigmoid intestine. In the third case, the patient was also diagnosed as having a malignant rectum polyp.

View Article and Find Full Text PDF